Autobio Diagnostics Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 1.51%

Autobio Diagnostics Co Ltd (603658) has an Asset Resilience Ratio of 1.51% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Autobio Diagnostics Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥185.18 Million

≈ $27.10 Million USD Cash + Short-term Investments

Total Assets

CN¥12.24 Billion

≈ $1.79 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Autobio Diagnostics Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Autobio Diagnostics Co Ltd balance sheet assets.

Liquid Assets Composition Over Time

This chart breaks down Autobio Diagnostics Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read 603658 total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥185.18 Million	1.51%
Total Liquid Assets	CN¥185.18 Million	1.51%

Asset Resilience Insights

Limited Liquidity: Autobio Diagnostics Co Ltd maintains only 1.51% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Autobio Diagnostics Co Ltd Industry Peers by Asset Resilience Ratio

Compare Autobio Diagnostics Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Eurobio Scientific SA PA:ALERS	Medical Devices	10.52%
Profound Medical Corp TO:PRN	Medical Devices	67.66%
EBR Systems Inc AU:EBR	Medical Devices	54.70%
Epitomee Medical Ltd TA:EPIT	Medical Devices	0.24%
Cleo Diagnostics Ltd AU:COV	Medical Devices	94.64%
Aligned Genetics Inc KQ:238120	Medical Devices	2.22%

Annual Asset Resilience Ratio for Autobio Diagnostics Co Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Autobio Diagnostics Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	4.09%	CN¥502.10 Million ≈ $73.47 Million	CN¥12.29 Billion ≈ $1.80 Billion	-26.01pp
2024-12-31	30.09%	CN¥3.57 Billion ≈ $522.93 Million	CN¥11.88 Billion ≈ $1.74 Billion	+3.83pp
2023-12-31	26.26%	CN¥3.03 Billion ≈ $443.98 Million	CN¥11.55 Billion ≈ $1.69 Billion	+26.18pp
2021-12-31	0.08%	CN¥7.34 Million ≈ $1.07 Million	CN¥9.23 Billion ≈ $1.35 Billion	-0.98pp
2020-12-31	1.06%	CN¥85.89 Million ≈ $12.57 Million	CN¥8.14 Billion ≈ $1.19 Billion	-1.77pp
2019-12-31	2.82%	CN¥120.16 Million ≈ $17.58 Million	CN¥4.26 Billion ≈ $622.91 Million	+2.79pp
2018-12-31	0.04%	CN¥931.48K ≈ $136.30K	CN¥2.66 Billion ≈ $388.74 Million	-17.71pp
2017-12-31	17.74%	CN¥388.09 Million ≈ $56.79 Million	CN¥2.19 Billion ≈ $320.07 Million	-25.78pp
2016-12-31	43.53%	CN¥792.80 Million ≈ $116.01 Million	CN¥1.82 Billion ≈ $266.53 Million	--

pp = percentage points

About Autobio Diagnostics Co Ltd

SHG:603658 China Medical Devices

Market Cap

$2.92 Billion

CN¥19.98 Billion CNY

Market Cap Rank

#5048 Global

#878 in China

Share Price

CN¥34.97

Change (1 day)

+7.53%

52-Week Range

CN¥28.72 - CN¥39.94

All Time High

CN¥131.73